The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment
NCT ID: NCT00564356
Last Updated: 2009-07-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
75 participants
INTERVENTIONAL
2007-07-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design: Consecutive prospective study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cataract Surgery in Patients With Pseudoexfoliation and Pseudoexfoliation Glaucoma
NCT04590651
Effect of Phacoemulsification on Ocular Blood Flow in Human
NCT01305005
Anterior Segment Changes After Phacoemulsification in Cataractous Eyes with Shallow Anterior Chamber
NCT06745596
Watering of the Eyes Following Uneventful Phacoemulsification Cataract Surgery
NCT05683613
Cataract Surgery on Advanced Age Related Macular Degeneration Patients
NCT04045704
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
patients under coumadin and antiaggregants operated by phacoemulsification
cataract surgery with phacoemulsification
removal of cataract with phacoemulsification technique
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cataract surgery with phacoemulsification
removal of cataract with phacoemulsification technique
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sheba Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ophira Salomon
Role: STUDY_DIRECTOR
Sheba Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheba Medical Center
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Barequet IS, Sachs D, Priel A, Wasserzug Y, Martinowitz U, Moisseiev J, Salomon O. Phacoemulsification of cataract in patients receiving Coumadin therapy: ocular and hematologic risk assessment. Am J Ophthalmol. 2007 Nov;144(5):719-723. doi: 10.1016/j.ajo.2007.07.029. Epub 2007 Sep 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHEBA-07-3017-OS-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.